These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36396603)

  • 21. Detrimental Effects of ApoE ε4 on Blood-Brain Barrier Integrity and Their Potential Implications on the Pathogenesis of Alzheimer's Disease.
    Kirchner K; Garvert L; Kühn L; Bonk S; Grabe HJ; Van der Auwera S
    Cells; 2023 Oct; 12(21):. PubMed ID: 37947590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of circulating C-reactive proteins, APOE ε4, and brain markers for Alzheimer's disease in healthy samples across the lifespan.
    Wang Y; Grydeland H; Roe JM; Pan M; Magnussen F; Amlien IK; Watne LO; Idland AV; Bertram L; Gundersen TE; Pascual-Leone A; Cabello-Toscano M; Tormos JM; Bartres-Faz D; Drevon CA; Fjell AM; Walhovd KW
    Brain Behav Immun; 2022 Feb; 100():243-253. PubMed ID: 34920091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?
    Lozupone M; Imbimbo BP; Balducci C; Lo Vecchio F; Bisceglia P; Latino RR; Leone M; Dibello V; Solfrizzi V; Greco A; Daniele A; Watling M; Seripa D; Panza F
    Alzheimers Dement; 2023 Jan; 19(1):353-368. PubMed ID: 35900209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropathology-based APOE genetic risk score better quantifies Alzheimer's risk.
    Deming Y; Vasiljevic E; Morrow A; Miao J; Van Hulle C; Jonaitis E; Ma Y; Whitenack V; Kollmorgen G; Wild N; Suridjan I; Shaw LM; Asthana S; Carlsson CM; Johnson SC; Zetterberg H; Blennow K; Bendlin BB; Lu Q; Engelman CD;
    Alzheimers Dement; 2023 Aug; 19(8):3406-3416. PubMed ID: 36795776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.
    Suh GH; Jung HY; Lee CU; Oh BH; Lee SK; Lee N; Kim J; Kee BS; Ko D; Kim YH; Ju YS; Hong I; Choi S;
    Dement Geriatr Cogn Disord; 2006; 21(1):33-9. PubMed ID: 16254428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of APOE gene with longitudinal changes of CSF amyloid beta and tau levels in Alzheimer's disease: racial differences.
    Xu C; Xiao D; Su BB; Saveron JM; Gamez D; Navia RO; Wang N; Roy U; Adjeroh DA; Wang K;
    Neurol Sci; 2024 Mar; 45(3):1041-1050. PubMed ID: 37759100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
    Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
    PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOE ε4 is associated with earlier symptom onset in LOAD but later symptom onset in EOAD.
    Polsinelli AJ; Lane KA; Manchella MK; Logan PE; Gao S; Apostolova LG
    Alzheimers Dement; 2023 May; 19(5):2212-2217. PubMed ID: 36722399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease.
    Laws SM; Taddei K; Martins G; Paton A; Fisher C; Clarnette R; Hallmayer J; Brooks WS; Gandy SE; Martins RN
    Neuroreport; 1999 Mar; 10(4):879-82. PubMed ID: 10208564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of
    Xicota L; Gyorgy B; Grenier-Boley B; Lecoeur A; Fontaine G; Danjou F; Gonzalez JS; Colliot O; Amouyel P; Martin G; Levy M; Villain N; Habert MO; Dubois B; Lambert JC; Potier MC;
    Neurology; 2022 Aug; 99(5):e462-e475. PubMed ID: 35606148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of HLA-DRB1/DQB1 Genetic Variants on Neuroimaging in Healthy, Mild Cognitive Impairment, and Alzheimer's Disease Cohorts.
    Wang ZX; Wang HF; Tan L; Liu J; Wan Y; Sun FR; Tan MS; Tan CC; Jiang T; Tan L; Yu JT;
    Mol Neurobiol; 2017 Jul; 54(5):3181-3188. PubMed ID: 27056075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E ε4 allele impairs cortical activity in healthy aging and Alzheimer's disease.
    Pedroso RV; Fraga FJ; Nascimento CMC; Pott-Junior H; Cominetti MR
    Behav Brain Res; 2022 Feb; 420():113700. PubMed ID: 34871705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
    Agarwal R; Tripathi CB
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Missing apolipoprotein E ε4 allele associated with nonamnestic Alzheimer's disease in a Tunisian population.
    Fray S; Achouri-Rassas A; Belal S; Messaoud T
    J Genet; 2022; 101():. PubMed ID: 36226340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease patients not carrying the apolipoprotein E ε4 allele show more severe slowing of oscillatory brain activity.
    de Waal H; Stam CJ; de Haan W; van Straaten EC; Blankenstein MA; Scheltens P; van der Flier WM
    Neurobiol Aging; 2013 Sep; 34(9):2158-63. PubMed ID: 23587637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Association of FERMT2, HLA-DRB1, CD2AP, and PTK2B Polymorphisms With Alzheimer's Disease Risk in the Southern Chinese Population.
    Yan Y; Zhao A; Qui Y; Li Y; Yan R; Wang Y; Xu W; Deng Y
    Front Aging Neurosci; 2020; 12():16. PubMed ID: 32116649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A haptoglobin (HP) structural variant alters the effect of APOE alleles on Alzheimer's disease.
    Bai H; Naj AC; Benchek P; Dumitrescu L; Hohman T; Hamilton-Nelson K; Kallianpur AR; Griswold AJ; Vardarajan B; Martin ER; Beecham GW; Below JE; Schellenberg G; Mayeux R; Farrer L; Pericak-Vance MA; Haines JL; Bush WS;
    Alzheimers Dement; 2023 Nov; 19(11):4886-4895. PubMed ID: 37051669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.
    Neu SC; Pa J; Kukull W; Beekly D; Kuzma A; Gangadharan P; Wang LS; Romero K; Arneric SP; Redolfi A; Orlandi D; Frisoni GB; Au R; Devine S; Auerbach S; Espinosa A; Boada M; Ruiz A; Johnson SC; Koscik R; Wang JJ; Hsu WC; Chen YL; Toga AW
    JAMA Neurol; 2017 Oct; 74(10):1178-1189. PubMed ID: 28846757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.